Salute e Benessere

LILYSILK Unveils Winter 2025 Collection "Framed Beauty," Celebrating Strength…

With clean lines, tailored silhouettes, and balanced proportions, the collection blends softness and strength in a refined expression of modern femininity. While materials such as silk-wool and cashmere-wool remain central, it is the sculptural design and architectural sensibility that truly set this collection apart. With clean lines, tailored silhouettes, and balanced proportions, the collection blends softness and strength in a refined expression of modern femininity. While materials such…
PR Newswire
23/09/2025

Major Shareholder Announcement

Company Announcement Major shareholder announcement for Genmab A/S COPENHAGEN, Denmark; September 23, 2025 –Genmab A/S(Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that Orbis Investment Management Limited has informed us that, as of September 19, 2025, Orbis Investment Management Limited through shares and ADRs, representing shares, controlled the voting rights to 3,230,732 shares in Genmab A/S, which amounts to 5.03% of the share...
Nasdaq GlobeNewswire
23/09/2025

VAPORESSO's Decade of Innovation: Elevating Vaping Aesthetics with the XROS 5…

Innovation as the Accelerator of a Decade's Excellence Innovation as the Accelerator of a Decade's Excellence Celebrating its 10th anniversary, VAPOREESO pays tribute to the legends of speed on the track by infusing its innovative spirit into the design of theInno-Speed Editions. These special editions incorporate a variety of racing-inspired design elements, combined with carbon fiber panels, supercar hand-drawn illustration, and a custom dashboard-style UI. Exclusively packaged as...
PR Newswire
23/09/2025

LabConnect Partners with The Bracken Group to Expand Radiopharmaceutical Support…

The Bracken Group (Bracken) is widely recognized for its scientific leadership and strategic expertise in the radiopharma space. Known for key opinion leadership and a broad scientific approach, Bracken brings unmatched insights across development, regulatory, and commercialization efforts. The Bracken Group (Bracken) is widely recognized for its scientific leadership and strategic expertise in the radiopharma space. Known for key opinion leadership and a broad scientific approach, Bracken...
PR Newswire
23/09/2025

Pictor Secures Funding to Accelerate U.S. Expansion through Partner-Informed…

Pictor will deploy the new capital to further fuel its market expansion and commercial operations across the United States following the successful establishment of its Carlsbad headquarters. The funding will also support and advance partner-driven product development initiatives, including expansion of the company's patented PictArray™ across both human and animal health applications. Pictor will deploy the new capital to further fuel its market expansion and commercial operations acrossthe...
PR Newswire
23/09/2025

Myriad Genetics and SOPHiA GENETICS to Develop an Innovative Companion…

SOPHiA GENETICS and Myriad will initially focus on the liquid biopsy application, MSK-ACCESS® powered with SOPHiA DDM™. Developed in collaboration with Memorial Sloan Kettering Cancer Center, MSK-ACCESS® powered with SOPHiA DDM™ is an innovative liquid biopsy test that detects actionable genomic alterations from a single blood draw using proprietary, state-of-the-art algorithms which analyze circulating tumor DNA (ctDNA). By developing the application into a CDx, more patients can gain access to…
PR Newswire
23/09/2025

KATE SPADE NEW YORK'S NEW CAMPAIGN, "SPARK SOMETHING BEAUTIFUL," BRINGS BACK…

Set against the bustling backdrop of New York City, we follow our protagonist as she navigates on her own...until she approaches a street crossing. As her friends join her, their togetherness sparks a transformation of the crossing into a celebration of how even a small moment of connection can spark something beautiful. Set against the bustling backdrop ofNew York City, we follow our protagonist as she navigates on her own...until she approaches a street crossing. As her friends join...
PR Newswire
23/09/2025

Amphista Therapeutics discloses first details of its TEAD Targeted Glue™ program…

Amphista Therapeutics discloses first details of its TEAD Targeted Glue™ program and unveils new mechanism of action for TEAD degradation via FBXO22First disclosure of a novel mechanism of action for the degradation of TEAD by selectively inducing its proximity to FBXO22 as a targeted molecular glue, leading to strong and rapid degradation of TEAD.Structurally-guided discovery using high-resolution cryo-EM has delivered TEAD Targeted Glues™ with exceptional potency.Firstin vivo...
Nasdaq GlobeNewswire
23/09/2025

BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October…

MAINZ, Germany, September 23, 2025 (GLOBE NEWSWIRE)-- BioNTech SE(Nasdaq: BNTX, “BioNTech”), alongside its artificial intelligence (“AI”) companyInstaDeep Ltd.(“InstaDeep”), will host its second AI Day, an edition of BioNTech’s “Innovation Series”, at 09:00 a.m. EDT (3:00 p.m. CEST) on Wednesday, October 1, 2025, in London, United Kingdom. The event will provide an overview of BioNTech’s AI strategy and capabilities, and the application of AI in BioNTech’s pipeline and internal...
Nasdaq GlobeNewswire
23/09/2025

Desenio unveils exclusive collections with home stylists Arvin Olvano, Reserve…

Each stylist worked together with Desenio over several months to create unique collections that allow fans and followers to have a little something from each stylist in their home. Arvin's collection is inspired by vintage art, Mallory's by artist's sketchbooks, while Saraa's collection sparks joy and colour. Each stylist worked together with Desenio over several months to create unique collections that allow fans and followers to have a little something from each stylist in their home...
PR Newswire
23/09/2025

AI in Oncology For Analytical Solutions Market Size & Share to Surpass $8.86…

This growth reflects the rising adoption of AI-driven tools for early detection, tumor subtyping, therapy selection, and real-world outcomes analytics. With the global cancer burden increasing, these solutions are enabling faster, more accurate clinical decisions while reducing costs and improving patient outcomes. This growth reflects the rising adoption of AI-driven tools for early detection, tumor subtyping, therapy selection, and real-world outcomes analytics. With the global cancer…
PR Newswire
23/09/2025

JOYROOM Launches the PR1 Retractable Power Bank: An Innovative Blend of Power…

Pocket-sized Power: Sleek, Compact and Ready to GoWeighing only 200g, the JR-PR1 slips easily into any pocket or bag. With 22.5W fast charging, it keeps devices running through commutes, workdays, and leisure moments. Pairing seamlessly with the new iPhone 17 series, it redefines pocket-sized power with style. Pocket-sized Power: Sleek, Compact and Ready to GoWeighing only 200g, the JR-PR1 slips easily into any pocket or bag. With 22.5W fast charging, it keeps devices running through...
PR Newswire
23/09/2025

Mindray Unveils Project 2030 and Re-writes the Future of Women's Health…

During the congress, Prof. Savino Gil Pugliese (Head of Fetal Surgery, University Hospital of Córdoba) and Prof. Roberto Albinagorta (ISUOG Ambassador to Latin America) delivered the scan demo session, steering the Mindray Nuewa R9 Platinum through first-trimester fetal hearts and complex gynecologic masses. Crystal-clear 4D, super-resolution color and smart quantification drew spontaneous applause from hundreds of delegates. "This is a new grammar for ultrasound storytelling,"…
PR Newswire
23/09/2025

Economist Impact's 5th edition Future of Health Asia returns to Singapore amid…

SINGAPORE, Sept. 23, 2025 /PRNewswire/ -- Convening on October 16th at the Four Seasons Hotel, the5th edition Future of Health Asiawill bring together 500 senior leaders from healthcare, government and patient advocacy to examine the impact of rising technological disruptions, rising pressure of chronic diseases and global economic uncertainty. SINGAPORE , Sept. 23, 2025 /PRNewswire/ -- Convening onOctober 16that the Four Seasons Hotel, the 5th edition Future of Health Asia will...
PR Newswire
23/09/2025

Santhera Announces Half Year 2025 Financial Results and Provides Corporate…

Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on September 23, 2025, at 14:00 CEST / 13:00 BST / 08:00 EDT.Details are at the end of this news releasePratteln, Switzerland, September 23, 2025–Santhera Pharmaceuticals (SIX: SANN) announces the Company’s financial results for the six months ended June 30, 2025, reports on progress with AGAMREE® (vamorolone) for the treatment of Duchenne muscular dystrophy (DMD) and provides updates on its corporate and...
Nasdaq GlobeNewswire
23/09/2025

Sweden, the world's first travel destination on prescription

Watch how experiences in Sweden can boost health: www.youtube.com/watch?v=hqo3PZwOZhk Watchhow experiences inSwedencan boost health :www.youtube.com/watch?v=hqo3PZwOZhk The new survey conducted by YouGov revealed that most respondents had not heard about nature, social or culture prescriptions by doctors. But nearly two out of three would be open to following them. "Nature, social settings and culture have restorative powers, and evidently,Swedenhas these assets in...
PR Newswire
23/09/2025

Invitation to presentation of Essity's interim report for quarter 3, 2025

Contact information for conference call with the possibility to ask questions:UK: +44 (0) 33 0551 02 00 USA: +1 786 697 35 01SWE: +46 (0)8 505 204 24Please call in well in advance of the start of the presentation. Indicate: "Essity". Contact information for conference call with the possibility to ask questions: UK: +44 (0) 33 0551 02 00 USA : +1 786 697 35 01 SWE: +46 (0)8 505 204 24 Please call in well in advance of the start of the presentation. Indicate…
PR Newswire
23/09/2025

SciBase receives initial order for clinical study from Castle Biosciences

Following the signing of the collaboration agreement, Castle has also invested in SciBase and is now SciBase second largest shareholder. Following the signing of the collaboration agreement, Castle has also invested in SciBase and is now SciBase second largest shareholder. "The collaboration with Castle Biosciences is moving forward at a fast pace and this first order signals the initiation of our first joint study," said Pia Renaudin , CEO of SciBase. "At SciBase we are very…
PR Newswire
23/09/2025

PioCreat Debuts PioNext Mini Dental 3D Printer at 2025 Moscow Dental Expo

The PioNext Mini is an ultra-compact, suitcase-style dental 3D printer (200 × 170 × 230 mm) that saves space and integrates curing in one device, making it easy to carry and ideal for chairside use. Designed for speed and efficiency, it produces crowns in just 10 minutes, while other common chairside applications can be completed within 30 minutes, all with ultra-high resolution for precise, aesthetic results. With the optional LD resin vat, clinicians can achieve smooth, high-translucency…
PR Newswire
23/09/2025

Santhera Announces Half Year 2025 Financial Results and Provides Corporate…

Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on September 23, 2025, at 14:00 CEST / 13:00 BST / 08:00 BST.Details are at the end of this news releasePratteln, Switzerland, September 23, 2025–Santhera Pharmaceuticals (SIX: SANN) announces the Company’s financial results for the six months ended June 30, 2025, reports on progress with AGAMREE® (vamorolone) for the treatment of Duchenne muscular dystrophy (DMD) and provides updates on its corporate and...
Nasdaq GlobeNewswire
23/09/2025

Press Release: Sanofi’s SAR446268 earns US fast track designation for the…

Sanofi’s SAR446268 earns US fast track designation for the treatment of non-congenital myotonic dystrophy type 1Designation earned for one-time AAV gene therapy SAR446268, designed to silence DMPK expressionMyotonic dystrophy type 1 (DM1) is a rare, genetic disorder that causes progressive muscle weakness and wasting, with no currently approved medicinesParis, September 23, 2025. The US Food and Drug Administration (FDA) has granted fast track designation to SAR446268, Sanofi's...
Nasdaq GlobeNewswire
23/09/2025

Santhera Secures CHF 20 Million Growth Funding to Accelerate Global AGAMREE®…

Ad hoc announcement pursuant to Art. 53 LR Highlights:Santhera secures approximately CHF 20 million of additional funding from existing investors Highbridge and R-Bridge to accelerate global rolloutDemand for AGAMREE® (vamorolone) in US/China ahead of plan; increased inventory needs and launch timing shifts drive need for incremental growth capitalPratteln, Switzerland, September 23, 2025 –Santhera Pharmaceuticals (SIX: SANN) today announces new financing agreements with...
Nasdaq GlobeNewswire
23/09/2025

Addex Appoints Bank of New York Mellon as Depositary Bank

Ad Hoc Announcement Pursuant to Art. 53 LRGeneva, Switzerland, September 23, 2025-Addex Therapeutics(SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today announced the appointment the Bank of New-York Mellon (BNY) as its new ADS depositary agent. This change is expected to become effective on October 6, 2025. The appointment of BNY has no impact on the...
Nasdaq GlobeNewswire
23/09/2025

Neuromod Advance Multiple Regulatory Approvals to Expedite Global Availability…

Following MDSAP certification Neuromod secured both Health Canada and TGA approval to place Lenire on the market in those territories. Following MDSAP certification Neuromod secured both Health Canada and TGA approval to place Lenire on the market in those territories. Tinnitus, which is commonly known as ringing in the ears, is a complex neurological condition that affects 15% of the global adult population 1. "Neuromod's commitment to delivering the highest quality of patient care...
PR Newswire
23/09/2025
Altri  Comunicati